Abstract
BackgroundThe only HIV pre-exposure prophylaxis (PrEP) regimen approved in Australia is daily co-formulated tenofovir and emtricitabine. As an alternative, on-demand PrEP could offer benefits, including lower pill burden for people...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
